CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE OMISSIONS HAVE BEEN INDICATED BY “[***].” THERAPEUTIC DEVELOPMENT AWARD...Therapeutic Development Award Agreement • March 29th, 2021 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • Maryland
Award Amount: $4,234,249, consisting of $484,249 previously advanced and up to an additional $3,750,000 in accordance with the Payment Schedule attached hereto as Exhibit B
